International Liver Congress

Meeting News

One-third of chronic hepatitis E cases transmitted through blood products

April 13, 2018
PARIS — Blood products were linked to 36% of chronic hepatitis E cases among a group of immunosuppressed patients, according to a study…
Meeting NewsVideo

Cost-effective liver cancer screening after HCV requires better risk cutoffs

April 13, 2018
PARIS — Researchers evaluated the cost-effectiveness of regular hepatocellular carcinoma screening among patients with hepatitis C after…
Meeting News

Thyroid receptor agonist for 12 weeks reduces hepatic fat in NASH

April 13, 2018
PARIS — Twelve weeks of MGL-3196 — an orally active, highly selective thyroid hormone receptor beta-selective agonist —…
Meeting News

Low food security increases risk for advanced fibrosis

April 13, 2018
PARIS — Food insecurity correlated with an increased risk for advanced fibrosis, particularly among patients with diabetes, according to a…
Meeting NewsVideo

$300 HCV combination reaches 97% cure rates in Malaysia, Thailand

April 13, 2018
PARIS — Using a new medication and generic sofosbuvir, researchers reached 97% sustained virologic response in patients with hepatitis C both…
Meeting News

Health care costs increase by over 90% after compensated cirrhosis diagnosis

April 13, 2018
PARIS — All-cause hospitalizations, rate of emergency visits and inpatient costs increased by more than 90% following compensated cirrhosis…
Meeting News

Italian hepatitis A outbreak among MSM linked to two European strains

April 12, 2018
PARIS — New data linked hepatitis A cases from an ongoing outbreak among men who have sex with men in the Lombardy region of Italy to strains…
Meeting News

Cenicriviroc shows safe long-term antifibrotic activity in adults with NASH

April 12, 2018
PARIS — Cenicriviroc, an oral C-C chemokine receptor type 2 and type 5 antagonist also known as CVC, was well-tolerated and provided…
Meeting News

Real-world experience confirms Mavyret efficacy in HCV

April 12, 2018
PARIS — Two real-world studies presented at the International Liver Congress 2018 confirmed the efficacy and safety of Mavyret in Italy and…
Meeting News

Multi-drug resistant infections increase mortality risk in cirrhosis

April 12, 2018
PARIS — Patients with cirrhosis who experienced a multi-drug resistant bacterial infection were less likely to respond to first-line treatment…